180 Life Sciences Stock Fundamentals
| ATNF Stock | USD 1.07 0.01 0.93% |
180 Life Sciences fundamentals help investors to digest information that contributes to 180 Life's financial success or failures. It also enables traders to predict the movement of 180 Stock. The fundamental analysis module provides a way to measure 180 Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 180 Life stock.
At this time, 180 Life's Selling And Marketing Expenses is most likely to increase significantly in the upcoming years. 180 | Select Account or Indicator |
180 Life Sciences Company Shares Owned By Insiders Analysis
180 Life's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current 180 Life Shares Owned By Insiders | 18.13 % |
Most of 180 Life's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 180 Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 18.13% of 180 Life Sciences are shares owned by insiders. This is 19.43% higher than that of the Biotechnology sector and 27.86% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 79.68% lower than that of the firm.
180 Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 180 Life's current stock value. Our valuation model uses many indicators to compare 180 Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 180 Life competition to find correlations between indicators driving 180 Life's intrinsic value. More Info.180 Life Sciences is rated below average in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, 180 Life's Return On Equity is most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value 180 Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.180 Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 180 Life's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 180 Life could also be used in its relative valuation, which is a method of valuing 180 Life by comparing valuation metrics of similar companies.180 Life is currently under evaluation in shares owned by insiders category among its peers.
180 Fundamentals
| Return On Equity | -1.74 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 6.49 M | ||||
| Shares Outstanding | 3.18 M | ||||
| Shares Owned By Insiders | 18.13 % | ||||
| Shares Owned By Institutions | 21.32 % | ||||
| Number Of Shares Shorted | 25.91 K | ||||
| Price To Earning | 0.63 X | ||||
| Price To Book | 0.92 X | ||||
| EBITDA | (22.13 M) | ||||
| Net Income | (19.94 M) | ||||
| Cash And Equivalents | 1.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 1.05 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 0.67 X | ||||
| Book Value Per Share | 3.64 X | ||||
| Cash Flow From Operations | (10.92 M) | ||||
| Short Ratio | 0.53 X | ||||
| Earnings Per Share | 7.98 X | ||||
| Target Price | 80.0 | ||||
| Beta | 0.22 | ||||
| Market Capitalization | 3.4 M | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (127.34 M) | ||||
| Working Capital | (1.42 M) | ||||
| Net Asset | 5.26 M |
About 180 Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 180 Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 180 Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 180 Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -1.7 T | -1.6 T | |
| Cost Of Revenue | 121.5 K | 110.9 K |
Currently Active Assets on Macroaxis
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:Check out 180 Life Piotroski F Score and 180 Life Altman Z Score analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.